Aurora Kinase Inhibitors in Head and Neck Cancer

被引：2
|
作者：
Qi, Guangying [1 ]
Liu, Jing [1 ]
Mi, Sisi [1 ]
Tsunematsu, Takaaki [2 ]
Jin, Shengjian [1 ]
Shao, Wenhua [1 ]
Liu, Tian [1 ]
Ishimaru, Naozumi [2 ]
Tang, Bo [1 ]
Kudo, Yasusei [2 ]
机构：
[1] Guilin Med Univ, Affiliated Hosp, Dept Pathol & Physiopathol Hepatobiliary Surg, Guilin 541000, Peoples R China
[2] Univ Tokushima, Inst Biomed Sci, Dept Oral Mol Pathol, Grad Sch, Tokushima 7708504, Japan
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2018年 / 18卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Aurora kinases; Mitosis; Head and neck cancer; Aurora kinase inhibitor; Tumor; Biological function; SMALL-MOLECULE INHIBITOR; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL PASSENGER PROTEIN; SPINDLE ASSEMBLY CHECKPOINT; HUMAN COLORECTAL CANCERS; SUPPRESSES TUMOR-GROWTH; CELLS IN-VITRO; SELECTIVE AURORA; B-KINASE; A KINASE;
D O I：
10.2174/1568026618666180112163741
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aurora kinases are a group of serine/threonine kinases responsible for the regulation of mitosis. In recent years, with the increase in Aurora kinase-related research, the important role of Aurora kinases in tumorigenesis has been gradually recognized. Aurora kinases have been regarded as a new target for cancer therapy, resulting in the development of Aurora kinase inhibitors. The study and application of these small-molecule inhibitors, especially in combination with chemotherapy drugs, represent a new direction in cancer treatment. This paper reviews studies on Aurora kinases from recent years, including studies of their biological function, their relationship with tumor progression, and their inhibitors.
引用
收藏
页码：199 / 213
页数：15
相关论文
共 50 条
  • [1] Emerging tyrosine kinase inhibitors for head and neck cancer
    Bossi, Paolo
    Locati, Laura
    Licitra, Lisa
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (04) : 445 - 459
  • [2] Emerging tyrosine kinase inhibitors for head and neck cancer
    Long, Zhen
    Grandis, Jennifer R.
    Johnson, Daniel E.
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 333 - 344
  • [3] Aurora kinases in head and neck cancer
    Mehra, Ranee
    Serebriiskii, Ilya G.
    Burtness, Barbara
    Astsaturov, Igor
    Golemis, Erica A.
    LANCET ONCOLOGY, 2013, 14 (10): : E425 - E435
  • [4] Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
    Hoellein, Alexander
    Pickhard, Anja
    von Keitz, Fabienne
    Schoeffmann, Stephanie
    Piontek, Guido
    Rudelius, Martina
    Baumgart, Anja
    Wagenpfeil, Stefan
    Peschel, Christian
    Dechow, Tobias
    Bier, Henning
    Keller, Ulrich
    ONCOTARGET, 2011, 2 (08) : 599 - 609
  • [5] The Aurora kinase inhibitors in cancer research and therapy
    Cicenas, Jonas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (09) : 1995 - 2012
  • [6] The Aurora kinase inhibitors in cancer research and therapy
    Jonas Cicenas
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1995 - 2012
  • [7] Therapeutic potential of Aurora kinase inhibitors in cancer
    Naruganahalli, Krishna S.
    Lakshmanan, Manikandan
    Dastidar, Sunanda G.
    Ray, Abhijit
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (12) : 1044 - 1051
  • [8] Aurora Kinase Inhibitors in Breast Cancer Treatment
    Opyrchal, Mateusz
    Sangameswaran, Kothai Divya Guruswamy
    Khoury, Thaer
    Boland, Patrick
    Galanis, Evanthia
    Haddad, Tufia C.
    D'Assoro, Antonino B.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (12) : 14 - 18
  • [9] Aurora Kinases as Therapeutic Targets in Head and Neck Cancer
    Nguyen, Theodore T.
    Silva, Flaviane N.
    Golemis, Erica A.
    CANCER JOURNAL, 2022, 28 (05): : 387 - 400
  • [10] Multi-kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
    Brands, Roman C.
    De Donno, Francesco
    Knierim, Marie Luise
    Steinacker, Valentin
    Hartmann, Stefan
    Seher, Axel
    Kuebler, Alexander C.
    Mueller-Richter, Urs D. A.
    ONCOLOGY LETTERS, 2019, 18 (03) : 2220 - 2231
12345